Synthesis ( IF 2.2 ) Pub Date : 2013-01-24 , DOI: 10.1055/s-0032-1318107 Uroš Grošelj 1 , Jurij Svete 1 , Anja Podlogar 1 , Ana Novak 1 , Georg Dahmann 2 , Amalija Golobič 1 , Branko Stanovnik 1
Dedicated to Professor Emeritus Volker Jäger, Institut für Organische Chemie, Universität Stuttgart, on the occasion of his 70th birthday.
Abstract
A series of tetrahydropyrazolo[1,5-c]pyrimidine-2,7(1H,3H)-diones 3a–h as the first representatives of the so far unexplored saturated heterocyclic system have been synthesized, formally in 12 steps from methyl acrylate (4). The synthesis comprises a four-step preparation of methyl N-Cbz-5-alkylamino-3-oxopentanoates 9a–c, their three-step transformation into 5-{2-[(alkyl)(benzyloxycarbonyl)amino]ethyl}pyrazolidin-3-ones 12a–c, three-step selective alkylation of the amidic N-2 to give 2-alkyl-5-{2-[(alkyl)(benzyloxycarbonyl)amino]ethyl}pyrazolidin-3-ones 16b–h, followed by hydrogenolytic Cbz-deprotection and subsequent cyclization of the intermediate 1,4-diamine with CDI to furnish the title compounds 3. Most of the synthetic steps were performed as a one-pot transformation.
A series of tetrahydropyrazolo[1,5-c]pyrimidine-2,7(1H,3H)-diones 3a–h as the first representatives of the so far unexplored saturated heterocyclic system have been synthesized, formally in 12 steps from methyl acrylate (4). The synthesis comprises a four-step preparation of methyl N-Cbz-5-alkylamino-3-oxopentanoates 9a–c, their three-step transformation into 5-{2-[(alkyl)(benzyloxycarbonyl)amino]ethyl}pyrazolidin-3-ones 12a–c, three-step selective alkylation of the amidic N-2 to give 2-alkyl-5-{2-[(alkyl)(benzyloxycarbonyl)amino]ethyl}pyrazolidin-3-ones 16b–h, followed by hydrogenolytic Cbz-deprotection and subsequent cyclization of the intermediate 1,4-diamine with CDI to furnish the title compounds 3. Most of the synthetic steps were performed as a one-pot transformation.
中文翻译:
四氢吡唑并[1,5-c]嘧啶-2,7(1H,3H)-二酮的合成
在他70岁生日之际,献给斯图加特大学有机化学研究所名誉教授VolkerJäger。
抽象
一系列四氢吡唑并[1,5- c ]嘧啶-2,7 (1 H,3 H)-二酮3a - h作为迄今未开发的饱和杂环系统的第一个代表已合成,从甲基开始以十二个步骤正式形成丙烯酸酯(4)。合成过程包括N -Cbz-5-烷基氨基-3-氧代戊酸甲酯9a-c的四步制备,将其三步转化为5- {2-[(烷基)(苄氧基羰基)氨基]乙基}吡唑啉丁-3 -a 12a – c,对酰胺基N-2进行三步选择性烷基化,得到2-烷基-5- {2-[((烷基)(苄氧羰基)氨基]乙基}吡唑啉丁-3-ones 16b– h,然后进行Cbz脱氢氢解,然后将中间体1,4-二胺与CDI环合,得到标题化合物3。大多数合成步骤都是一锅法进行的。
一系列四氢吡唑并[1,5- c ]嘧啶-2,7 (1 H,3 H)-二酮3a - h作为迄今未开发的饱和杂环系统的第一个代表已合成,从甲基开始以十二个步骤正式形成丙烯酸酯(4)。合成过程包括N -Cbz-5-烷基氨基-3-氧代戊酸甲酯9a-c的四步制备,将其三步转化为5- {2-[(烷基)(苄氧基羰基)氨基]乙基}吡唑啉丁-3 -a 12a – c,对酰胺基N-2进行三步选择性烷基化,得到2-烷基-5- {2-[((烷基)(苄氧羰基)氨基]乙基}吡唑啉丁-3-ones 16b– h,然后进行Cbz脱氢氢解,然后将中间体1,4-二胺与CDI环合,得到标题化合物3。大多数合成步骤都是一锅法进行的。